Home › Funds › Hemenway Trust Co LLC › VRTX

Hemenway Trust Co LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Hemenway Trust Co LLC reported holding 57,880 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$30.3M, representing 2.24% of its reported portfolio and ranking #21 among its reported holdings. Hemenway Trust Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)57.88K sh
Reported value held$30.26M
Portfolio Weight2.24%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hemenway Trust Co LLC's VRTX position evolved

Hemenway Trust Co LLC first disclosed a stake in VRTX in Q3 2023 at 3,766 shares (US$1.3M). The position peaked in Q3 2026 at 57,880 shares, worth US$30.3M. Across 13 filings, Hemenway Trust Co LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 57,880 shares valued at US$30.3M — an increase of 1,885 shares quarter over quarter.. Notable position changes include a 231% increase in Q1 2024 (shares rose 12% over the following quarter), a 83% increase in Q2 2024 (shares were roughly flat over the following quarter), a 41% increase in Q3 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.77K $1.31M New
Q4 2023 4.68K $1.91M Add
Q1 2024 15.52K $6.49M Add
Q2 2024 28.44K $13.33M Add
Q3 2024 40.12K $18.66M Add
Q4 2024 49.41K $19.90M Add
Q1 2025 54.32K $26.34M Add
Q2 2025 55.52K $24.72M Add
Q3 2025 55.12K $21.59M Reduce
Q4 2025 51.02K $23.13M Reduce
Q1 2026 51.50K $23.00M Add
Q2 2026 55.99K $27.81M Add
Q3 2026 57.88K $30.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Hemenway Trust Co LLC held VRTX?

Hemenway Trust Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hemenway Trust Co LLC's current position in VRTX?

As of Q3 2026, Hemenway Trust Co LLC holds 57.88K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $30.26M, representing 2.24% of its reported portfolio and ranking #21.

Has Hemenway Trust Co LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Hemenway Trust Co LLC increased its position in VRTX. The position peaked in Q3 2026 at 57.88K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.